FDA rejection of copyright therapy for PTSD highlights critical ethical and scientific issues in copyright drugs.Having said that, the role of these interactions and how they lead to the copyright knowledge continues to be subject matter to on-going scientific investigation. Subjective effectsThe physical results of 2C-B-FLY are similar to that of